INCY - Educational Analysis * US Equities
Educational Analysis * US Equities

INCY

Earnings behavior, post-earnings drift, and the gap between consensus and the market's real expectation - the educational primer before you look at the institutional verdict.

Educational content only - not investment advice. Nothing on this page is a recommendation to buy or sell any security. Historical patterns do not predict future outcomes. Consult a licensed financial advisor before making any trading decision.
Published byGamma QC editorial
TickerINCY
CategoryEducational primer
Last reviewedAugust 3, 2026
You're viewing an older edition of this page.Read the latest edition →

How INCY's Historical Earnings Stats Translate Into Price Behavior

Over the last eight reported quarters, Incyte (INCY) has beaten the published consensus five times, giving it a 62% beat rate with an average earnings surprise of 15.5%. That 15.5% average captures the magnitude of beats but also masks what happens on the tape. In the most recent four quarters, positive surprises included a 43.7% beat on 2026-07-28, a 35.1% beat on 2026-04-28, and a 36.1% beat on 2025-10-28—yet the next-day price responses were -2.18%, +1.39%, and -1.6%, respectively. The single miss in that window, on 2026-02-10 with a -5.3% surprise, produced a -1.21% next-day move.

Where the historical pattern becomes more consistent is in the five-trading-day drift after the report. Across the full eight-quarter sample, INCY's average 5-day post-earnings move is 4.99%, classified as an "up" drift. In the most recent four quarters, those five-day moves were 0%, -0.28%, +2.94%, and +12.3%. The 12.3% move after the 2025-10-28 report is the standout, while the 2026-07-28 quarter showed no net five-day drift despite the 43.7% beat. For traders, this split between an earnings-day headline reaction and a multi-day drift is the key dynamic to study: the Healthcare/Biotechnology sector's flow can re-price a stock over several sessions even when the initial print is read as mixed.

Options-Flow Dynamics Around the October 27 Earnings Date

The next scheduled report is on 2026-10-27 before the open, with a consensus EPS estimate of $-2.47. Because INCY has averaged a 15.5% earnings surprise and a 4.99% five-day post-earnings drift, options implied volatility typically expands into the release. Market participants may position for either direction using the 2026-10-27 date as the gamma/volatility anchor. With the current price at $118.6173, the 50-day EMA at $111.78, and RSI at 53.6, the stock is sitting in a relatively neutral technical posture above a rising short-term average.

In this environment, options flow can be read as a tension between capture of a volatility event and capture of direction. Historical results show that owning only the earnings-day direction has been unreliable—a 43.7% beat still sold off -2.18% the next session—while the five-day drift has usually been positive. That mismatch can keep both call and put premium elevated right up to expiration, especially for options expiring shortly after 2026-10-27. Traders watching order flow should separate near-the-money gamma from the broader directional skew; a high put/call skew, for example, may indicate hedging of downside gap risk rather than a bearish conviction.

What a Disciplined Trader Watches Before INCY Reports

A disciplined approach starts with the fact set: 62% beat rate, 15.5% average surprise, and a 4.99% average five-day drift to the upside. Rather than trading the headline, a risk-focused trader watches for a few specific inputs. First, compare the published consensus of $-2.47 to the market's real expectation embedded in recent options flow and analyst revisions. Second, test the technical levels: price is at $118.6173, above the 50-day EMA of $111.78, so the post-earnings range can be framed around that moving-average support. Third, match the expected implied-move pricing to the realized post-earnings moves—recent five-day outcomes of 0%, -0.28%, +2.94%, and +12.3% illustrate that realized movement has varied widely.

Finally, watch how the stock handles the first 24 to 48 hours after the release. The pattern in 2026-07-28 showed no five-day drift despite a massive beat, while 2025-10-28 showed a strong multi-day run. Waiting for the initial volatility to settle and then re-evaluating the five-day drift setup is one way to stay aligned with the historical tendency rather than fighting the opening print.

For a deeper dive into how institutional investors and options markets are positioning around INCY's 2026-10-27 report, see the full institutional verdict on the ticker page.

Frequently Asked Questions

What is INCY's historical earnings beat rate and average surprise?

Over the last eight reported quarters, INCY beat the consensus five times, a 62% beat rate, with an average earnings surprise of 15.5%.

How has the stock typically moved in the five trading days after earnings?

Across the last eight quarters, the average five-day drift after earnings was 4.99%, classified as up. In the most recent four quarters, the five-day moves were 0%, -0.28%, +2.94%, and +12.3%.

When is INCY's next earnings report and what is the consensus EPS estimate?

INCY is scheduled to report on 2026-10-27 before the market open, with the current consensus EPS estimate at $-2.47.

Real Data - Gamma QC Earnings IntelligenceAs of Aug 3, 2026
Incyte Corporation · Healthcare / Biotechnology
$24.0BMarket cap
14.6P/E
27.7%Net margin
29.7%ROE
62%Beat rate, last 8Q
15.5%Avg EPS surprise
4.99%Avg 5-day move after earnings
2026-10-27Next earnings
ReportedActualEstimateSurprise1D Move5D Move
2026-07-28$3.09$2.15+43.7%-2.18%null%
2026-04-28$1.81$1.34+35.1%+1.39%-0.28%
2026-02-10$1.8$1.9-5.3%-1.21%+2.94%
2025-10-28$2.26$1.66+36.1%-1.6%+12.3%
2025-07-29$1.57$1.39+12.9%--
2025-04-29$1.16$1.01+14.9%--

Previous INCY editions

Beyond the primer

Get the institutional verdict on INCY

Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.

Read the INCY verdict at Gamma QC
$49 Pro / $249 RIA * gammaqc.com

Verify authenticity

Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.